- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.03. | Tribune gains funds to advance scar tissue therapies | ||
| 27.03. | EC approves MSD's pneumococcal 21-valent conjugate Capvaxive | ||
| 26.03. | Unmatched quality in pharmaceutical logistics: Why it matters | ||
| 26.03. | FDA approves GSK's Blujepa for uncomplicated UTIs | ||
| 26.03. | Big pharma faces headwinds in China as vaccine sales decline | ||
| 26.03. | MHRA launches new monthly safety bulletins | ||
| 26.03. | Cassava ends simufilam Alzheimer's programme after second Phase III failure | ||
| 26.03. | FDA fast tracks Sanofi's mRNA vaccine for chlamydia | ||
| 26.03. | Character Biosciences gains $93m for precision eye disease therapies | ||
| 26.03. | MSD makes licence agreement with Hengrui Pharma for Lp(a) inhibitor | ||
| 25.03. | GSK and UK researchers plan to study Shingrix and dementia risk reduction link | ||
| 25.03. | Novo Nordisk earmarks $2bn for Chinese "triple G" weight loss shot | ||
| 25.03. | Alumis and Kaken sign agreement in Japan to develop ESK-001 | ||
| 25.03. | WuXi AppTec sells UK-US units, but annual results show foreign contracts continue despite China tensions | ||
| 25.03. | Overcoming regulatory challenges in sterile manufacturing | ||
| 25.03. | UKHSA unveils high-risk pathogen list to drive innovation | ||
| 25.03. | Trump tariffs drive pharma manufacturing to US but risk inflation and disruption | ||
| 25.03. | EMA to review GSK's Nucala for COPD treatment expansion | ||
| 25.03. | Sermonix and Regor to enhance breast cancer treatment options | ||
| 24.03. | Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry | ||
| 24.03. | Tempero secures $70m to advance addiction treatment candidate | ||
| 24.03. | Valneva outlays 40,000 vaccines to Réunion amidst chikungunya surge | ||
| 24.03. | Rising Sirturo resistance highlights urgent need for new TB therapies | ||
| 24.03. | Alberta partners Siemens and the Alberta Cancer Foundation | ||
| 24.03. | Augustine secures $85m to advance Charcot-Marie-Tooth candidate |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
